Drug Maker Asks Japan To Slow Prescribing Anti-Smoking Drug
This article was originally published in PharmAsia News
Executive Summary
Japan medical institutions have been asked by U.S.-based Pfizer to slow their prescription-writing for its Champix (varenicline) smoking-cessation drug